Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Antex Biologics (ANTX) -- Ignore unavailable to you. Want to Upgrade?

To: Amigo Mike who wrote (797)	3/31/1998 10:12:00 PM
From: LPasko	Read Replies (1) \| Respond to of 1476

I may have missed this: how many shares are currently outstanding?

To: Amigo Mike who wrote (797)	3/31/1998 10:21:00 PM
From: Joseph Wisnowski	Read Replies (2) \| Respond to of 1476

Michael: I'm in the same camp with you & RIP concerning the future of ANTX especially with its drugs , patents and collaborating partners. I realize an increase in share price is needed for listing and increased awareness to the investment world, but I was at the point to increase my holdings in ANTX when the Edgaar alert flashed. From past experience, a drop in price can be expected prior to the split and after with a base consolidation to follow. I do believe in the future of this co., but don't know for the short term with additional investment. Looking forward to any additional comments. Best Regards, Joe P.S. Michael, I'm new to SI and your 3A thread is a joy to read. Top notch with just the right mix of humor and professionalism. Good luck to you and your great group.